Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
- PMID: 36717871
- PMCID: PMC9886419
- DOI: 10.1186/s40545-022-00497-x
Bridging the gap? Local production of medicines on the national essential medicine lists of Kenya, Tanzania and Uganda
Abstract
Background: Essential medicines (EMs) are those that satisfy the basic healthcare needs of the population. However, access to EMs remains a global health challenge. The World Health Organization (WHO) and the East African Community (EAC) manufacturing plan 2017-2027 support local production of EMs as a strategy to improve access to medicines. The aim of this study was to determine for each therapeutic class on the national essential medicine lists (NEMLs) of Kenya, Tanzania and Uganda, the number of EMs produced in each country.
Methods: In 2018, we analysed NEMLs and national drug registers (NDRs) in each country to identify local manufacturers and local products by EM status. For each local manufacturer we determined the number of EM products and individual EMs, and analysed EMs in each therapeutic class by registration status and whether produced locally.
Results: There were nine companies manufacturing locally in Kenya, four in Tanzania and six in Uganda. Most local medicine products were non-EM products. Of the 946 locally produced products in Kenya, 310 were EM products; of the 97 locally produced products in Tanzania, 39 were EM products; and of the 181 locally produced products in Uganda, 100 were EM products. Many local EM products were duplicate. Only a small proportion of EMs on each NEML were produced locally: 21% (92/430) in Kenya, 5% (24/510) in Tanzania, and 10% (55/526) in Uganda. Kenya, Tanzania and Uganda had no local EM products in 13/32, 17/28 and 15/32 therapeutic classes, respectively. The proportion of EMs that were registered varied across the countries from 327 (76%) in Kenya, 269 (53%) in Tanzania, and 319 (60%) in Uganda.
Conclusions: This study highlights the importance of auditing NDRs and NEMLs for local production to inform regional and national local manufacturing strategies. EMs should be prioritized for local production and drug registration to ensure that production is aligned with local health needs.
Keywords: Access to medicines; East African Community; Essential medicines; Kenya; Local production; Low-and-middle-income countries; Medicine registration; Public health; Tanzania; Uganda.
© 2023. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests
Figures
Similar articles
-
Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis.J R Soc Med. 2023 Oct;116(10):331-342. doi: 10.1177/01410768231181263. Epub 2023 Jun 21. J R Soc Med. 2023. PMID: 37343667 Free PMC article.
-
Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018.Bull World Health Organ. 2020 Aug 1;98(8):530-538. doi: 10.2471/BLT.19.249433. Epub 2020 Jun 19. Bull World Health Organ. 2020. PMID: 32773898 Free PMC article.
-
The role of government agencies and other actors in influencing access to medicines in three East African countries.Health Policy Plan. 2021 Apr 21;36(3):312-321. doi: 10.1093/heapol/czaa189. Health Policy Plan. 2021. PMID: 33569583 Free PMC article.
-
Essential medicines availability is still suboptimal in many countries: a scoping review.J Clin Epidemiol. 2018 Jun;98:41-52. doi: 10.1016/j.jclinepi.2018.02.006. Epub 2018 Feb 13. J Clin Epidemiol. 2018. PMID: 29452222
-
The legal aspect of the current use of genetically modified organisms in Kenya, Tanzania, and Uganda.GM Crops Food. 2023 Dec 31;14(1):1-12. doi: 10.1080/21645698.2023.2208999. GM Crops Food. 2023. PMID: 37158150 Free PMC article. Review.
Cited by
-
Economic assessment of potential changes to essential medicines for diabetes in Uganda.PLoS One. 2025 Jun 25;20(6):e0326806. doi: 10.1371/journal.pone.0326806. eCollection 2025. PLoS One. 2025. PMID: 40560893 Free PMC article.
-
Cost and availability of selected medicines after implementation of increased import verification fees.BMC Health Serv Res. 2024 Jan 4;24(1):25. doi: 10.1186/s12913-023-10433-7. BMC Health Serv Res. 2024. PMID: 38178109 Free PMC article.
-
Establishing links between drug registers and essential medicines lists.Bull World Health Organ. 2025 Jan 1;103(1):37-42. doi: 10.2471/BLT.24.291512. Epub 2024 Oct 29. Bull World Health Organ. 2025. PMID: 39780996 Free PMC article.
-
Investigating pharmaceutical product recalls due to discolouration: a Kenyan case review (January 2016-December 2024).J Pharm Policy Pract. 2025 Jul 2;18(1):2522314. doi: 10.1080/20523211.2025.2522314. eCollection 2025. J Pharm Policy Pract. 2025. PMID: 40612011 Free PMC article.
References
-
- Chan M. Ten years in public health. [Online]. 2017. https://apps.who.int/iris/bitstream/handle/10665/255355/9789241512442-en.... Accessed 13th Dec 2019.
-
- World Health Organization. Interagency statement on promoting local production of medicines and other health technologies. [Online]. https://www.unaids.org/en/resources/presscentre/pressreleaseandstatement.... Accessed 13th Jan 2020.
-
- World Health Organization. Local production and access to medicines in Low-and middle-income countries A literature review and critical analysis. [Online]. 2011. https://medeor.de/images/themen/konferenz/Local_Production_Literature_Re.... Accessed 25th Nov 2019.
-
- World Health Organization. Local production for access to medical products: developing a framework to improve public health. [Online]. 2011. https://www.who.int/phi/publications/Local_Production_Policy_Framework.pdf. Accessed 13th Jan 2020.
LinkOut - more resources
Full Text Sources
Miscellaneous